US2020138769A1PendingUtilityA1

Pharmaceutical composition

Assignee: NUMAZAWA TOSHIHIKOPriority: Jul 7, 2016Filed: Jul 6, 2017Published: May 7, 2020

Est. expiryJul 7, 2036(~9.9 yrs left)· nominal 20-yr term from priority

Inventors:Toshihiko Numazawa

A61P 25/18A61P 25/00A61P 3/02A61K 31/27A61P 25/24

PatentIndex Score

Cited by

References

Claims

Abstract

where R represents an alkyloxy group having 1 to 3 carbon atoms or a halogen group.

Claims

exact text as granted — not AI-modified

1 . One or more kinds of compounds of the following structure are contained in the present pharmaceutical composition for treating mood disorders, mental disorders, and/or chronic fatigue syndrome: 
       
         
           
           
               
               
           
         
         (In the formula, R is an alkyloxy group containing 1 to 3 carbon atoms or a halogen group). 
       
     
     
         2 . The pharmaceutical composition according to  claim 1 , wherein R is a methoxy group or a chloro group. 
     
     
         3 . The pharmaceutical composition according to  claim 1 , wherein the compound is chlorphenesin carbamate and/or methocarbamol. 
     
     
         4 . The pharmaceutical composition according to  claim 1 , including chlorphenesin carbamate and methocarbamol.

Join the waitlist — get patent alerts

Track US2020138769A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.